Minute virus of mice (MVMp) infection and NS1 expression induce p53 independent apoptosis in transformed rat fibroblast cells  by Mincberg, Michal et al.
Virology 412 (2011) 233–243
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roMinute virus of mice (MVMp) infection and NS1 expression induce p53 independent
apoptosis in transformed rat ﬁbroblast cells
Michal Mincberg a,⁎, Jacob Gopas b,c, Jacov Tal a
a Department of Virology and Developmental Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
b Shraga Segal Department of Microbiology and Immunology, Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel
c Laboratory of Oncology, Soroka University Medical Center, Beer Sheva, Israel⁎ Corresponding author. Fax: +972 8 627 6215.
E-mail address: ytal@bgumail.bgu.ac.il (J. Tal).
0042-6822/$ – see front matter © 2011 Elsevier Inc. Al
doi:10.1016/j.virol.2010.12.035a b s t r a c ta r t i c l e i n f oArticle history:
Received 4 August 2010
Returned to author for revision
10 September 2010
Accepted 20 December 2010
Available online 3 February 2011
Keywords:
Minute virus of mice
MVM
Parvovirus
Apoptosis
p53
Caspase
Mitochondria
Cell cycle arrestParvoviruses infect and kill tumor cells in vivo and in vitro more efﬁciently than normal cells. Infection of
transformed cells by the parvovirus minute virus of mice (MVM) results in high expression of the major non-
structural cytolytic viral protein NS1, which induces a cell death modulated by cellular factors. In this work,
we show that MVMp infection and/or NS1 protein expression in permissive transformed rat ﬁbroblast cells
leads to apoptosis in wild type and p53−/− cells. Apoptotic cell morphology correlates with mitochondrial
membrane permeabilization and activation of caspases 9 and 3 but not caspase 8. Thus, further
characterization of the antitumor activity of MVMp and its NS1 protein may contribute to the eradication
of tumors, including those lacking p53.l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Autonomous parvoviruses are small, nonenveloped viruses with
linear single-stranded DNA genomes. These viruses rely heavily on a
wide range of the host cellular mechanisms for their ongoing life cycle
because of their limited coding capacity.
Minute virus of mice, MVMp, is a member of this family. Its 5200nt
genome is ﬂanked by palindromic termini of different sequences that
are required for replication and packaging of the viral genome. The
MVM genome harbors two transcription units: one, driven by the
early promoter, P4, encodes the non-structural regulatory proteins
NS1 and NS2 (Ahn et al., 1989; Clemens and Pintel, 1988; Pitluk and
Ward, 1991; Spegelaere et al., 1991), and the second, driven by the
late promoter, P38, encodes the structural viral capsid proteins VP1
and VP2 (Cotmore and Tattersall, 1987; Lorson et al., 1996; Schoborg
and Pintel, 1991; Soong et al., 1997).
NS1, the major non-structural protein is a mainly nuclear phospho-
protein involved in essential stages of the viral life cycle, including DNA
replication, trans-regulation of the twoviral promoters, andmodulation
of heterologous promoters (Caillet-Fauquet et al., 1990; Christensen et
al., 1995; Legendre and Rommelaere, 1992; Legendre and Rommelaere,1994; Lorson and Pintel, 1997). During viral replication, NS1 exhibits
DNA binding, endonuclease, and helicase activities on the parvoviral
genome and is a major contributor to the toxic effect on host cells. NS1
interacts with the cellular transcription factors SP1, TFIIA(α/β) and TBP
in vitro (Krady andWard, 1995; Lorson et al., 1998). The transcriptional
coactivator CREB binding protein, CBP, interacts with NS1, potentiating
viral and cellular gene expression including MVMp-p38 promoter
activity (Ohshima et al., 2001).
The replication of MVMDNA depends on cellular functions, starting
at the G1/S transition and continuing through S-phase (Cotmore and
Tattersall, 1987; Hardt et al., 1983). The availability of these cellular
factors depends largely on the proliferative activity and differentiation
state of the host cell. The efﬁciency of viral DNA replication and gene
expression is enhanced in oncogene-transformed cells and is charac-
terized by cytopathic features that result in host cell death, (Guetta et al.,
1990; Rommelaere and Cornelis, 1991; Salome et al., 1990). Parvo-
viruses trigger cell death through several pathways including apoptosis
(Best et al., 2003; Di Piazza et al., 2007; Hsu et al., 2004; Ohshima et al.,
1998; Poole et al., 2004; Ran et al., 1999; Rommelaere and Cornelis,
1991; Timpe et al., 2007). Infection with other autonomous parvo-
viruses like B19 or H-1 induced caspase 3 dependent apoptosis
(Moehler et al., 2001; Ohshima et al., 1998; Poole et al., 2004; Rayet
et al., 1998). In addition, Adeno-associated virus (AAV)whichbelongs to
the Dependvirus genus, induces apoptosis in infected cells that lack
active p53 (Moehler et al., 2001; Raj et al., 2001; Sieben et al., 2008).
234 M. Mincberg et al. / Virology 412 (2011) 233–243The details of cell death mobilized by parvovirus host–cell in-
teractions are varied and highly dependent on host–cell physiology
and the virus cell reciprocal. The correlation between parvoviruses
and apoptosis has been described for other autonomous parvoviruses,
particularly H-1, but not for MVM. These interactions are partially
responsible for their characteristic oncotropism and therefore also a
foundation for developing parvovirus-based oncotherapy (Wollmann
et al., 2005) and gene therapy vectors (Enderlin et al., 2009).
For these reasons, we investigate here the relationship between
MVM infection and/or transfectionwith the viral NS protein and host–
cell apoptosis.Results
Apoptosis is induced by MVMp infection and NS1 expression
Although some parvoviruses are known to induce apoptosis, it was
not known whether MVMp kills cells by apoptosis. To determineFig. 1. Apoptosis in PyF cells following MVM infection or NS1 expression. PyF cells were infec
control vector pCDNA3.1. Thirty hours after treatment, the cells were analyzed. A. Uninfec
apoptotic cells. B. PyF cells were transfected with the vector, pCDNA3.1 (1) or with pCDNA-N
pCDNA-NS1 was determined by immunoﬂuorescence (×100) (green) (3). C. Apoptotic cellwhether MVMp induces programmed cell death, we used trans-
formed PyF cells that are highly permissive to MVMp infection,
exhibiting high NS1 expression levels and MVMp-induced cytolysis.
The cells were infected with 5 pfu/cell of virus or transfected with
either pCDNA-NS1 plasmid or the control plasmid vector, pCDNA3.1.
NS1 expression, a marker of virus replication was evaluated by im-
munoﬂuorescence in 30 h post treatment NS1-transfected cells.
MVMp infection and NS1 expression both resulted in cell death that
included nuclear morphological changes characteristic of apoptosis
(condensed and fragmented nuclei) in 22% of infected cells (Fig. 1C)
and in 17% of transfected cells expressing NS1 (45%) (Fig. 1B and C).
Apoptotic morphology was rarely observed in control.Caspase 9 and caspase 3, but not caspase 8, are activated in
MVMp-induced apoptosis
Caspases are prominently involved in the complex proteolytic
cascades that are part of both the extrinsic and intrinsic apoptosisted with MVMp (5 pfu/cell) or transfected with 7 μg of pCDNA-NS1 plasmid, or with the
ted and infected cells were stained with DAPI. Arrows indicate nuclear breakdown of
S1 (2) and stained with DAPI (×400) (blue). NS1 expression in PyF transfected cells with
morphology was scored in infected and transfected cells.
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apoptotic morphology, we investigated whether caspase 8, caspase 9
and caspase 3 activation occurs. MVMp-permissive PyF cells were
infected with the virus. Cell lysates were obtained at different times
post infection and caspase activation was determined. Western blot
analysis of caspase 8 showed that viral infection did not induce
procaspase-8 cleavage (Fig. 2). Since this result suggested that
MVMp-induced apoptosis does not involve the membrane-associated
extrinsic pathway, caspase 9 and caspase 3 enzymatic activities,
which are activated in the intrinsic pathway, were determined. As a
positive control, we used PyF cells transfected with pHAtBID. This
plasmid expresses a truncated (activated) Bid (t-Bid), that translo-
cates to the mitochondria and triggers the intrinsic apoptotic
program. At deﬁned times after infection or transfection, cell lysates
were prepared and both caspase 9 and caspase 3 activities were
analyzed. Caspase-9 enzymatic activity was measured using the
speciﬁc ﬂuorogenic peptide substrate LEHD-AMC. Caspase 3 enzy-
matic activity was measured using the colorimetric substrate Ac-
DEVD-pNA, in the presence or absence of the speciﬁc inhibitor Ac-
DEVD-CHO. The results showed that both caspase-9 (Fig. 3A) and
caspase-3 (Fig. 3B) activity increased post infection, suggesting that
MVMp activates the mitochondrial apoptotic pathway.MVMp infection induces mitochondrial membrane depolarization
Mitochondrial membrane depolarization is a feature of apoptosis
that results in increasedmitochondrial membrane permeability (MMP)
and facilitates release of proapoptotic factors. To conﬁrm the role of the
mitochondria in the induction of apoptosis by MVMp, we determined
mitochondrial membrane potential (Δψm) following infection. To
this end, we used the ﬂuorescent lipophilic cation dye DiOC6 3, 3-
dihexyloxacarbocyanine iodide,whose incorporation intomitochondria
depends upon the mitochondrial inner membrane potential. The
mitochondrial-uncoupling reagent CICCP, which induces mitochondrial
membrane depolarization, was used as a positive control. At deﬁned
times after infection, ﬂow cytometric analyses of cytosolic fractions
isolated from stained PyF-infected and non-infected cells were carried
out. The results showed a time-dependent reduction in mitochondrial
membrane potential and increased cell death after infection (Fig. 4).Fig. 2. Caspase 8 protein levels in Pyf cells infected with MVMp. PyF cells were infected
with MVMp (5 pfu/cell). Cell lysates were prepared at the indicated time post infection.
Protein extracts from each sample were subjected to 10% PAGE and analyzed by
Western blot using an anti-caspase 8 polyclonal antibody (A) and an anti-actin
monoclonal antibody (B).Mitochondrial proteins are involved in the MVMp apoptotic pathway
We further investigated induction of the mitochondria apoptosis
pathway following MVMp infection using the Apoptosis Antibody
Array (Hypometrix) which recognizes inner cytosolic proteins
involved in apoptosis. Cytosolic fractions from mock-treated and
MVM-infected (24 h.p.i.) PyF cells were prepared and incubated with
the antibody array membrane. Results were quantitated using
Quantity One (Bio-Rad) (Fig. 5). The data showed that proteins
involved in mitochondrial apoptosis pathway, BAX, Apaf1 caspase 3,
and cytochrome c were signiﬁcantly elevated in infected cells.
Activation of caspase 3 and caspase 9 were conﬁrmed by enzymatic
assay (Fig. 3). The results are consistent with the initial data and
strengthen the conclusion that MVMp infection induces apoptosis
through the mitochondrial pathway.
MVMp–NS1 induced apoptosis is independent of p53 activity
Viral gene products can interact with p53 and in consequence
modulate the known role of p53 in apoptosis (Lagunas-Martinez et al.,
2009; Sun et al., 2008; Cao et al., 2004). It has been reported that
MVMp infection leads to p53 accumulation and cell cycle arrest in the
S and G2 phases following infection of FREJ4-transformed rat
ﬁbroblast cells (Op De Beeck et al., 2001). We further explored the
possibility that p53 is involved in MVMp and/or NS1-induced
apoptosis. To determine whether p53 is upregulated upon infection
with MVMp, PyF cells were infected for 16 or 24 h, and NS1 and p53
accumulation determined by Western blotting (Fig. 6). The results
showed an accumulation of NS1 typical of productive infection
(Fig. 6B). During the course of this infection the levels of p53 did
not increase so, it is unlikely that MVMp infection raises p53 activity
and may even repress it. We therefore characterized MVMp infection
and cell death in cell lines deﬁcient in p53 activity, a p53 knockout
(p53−/−) (Jacks et al., 1994) and a p53 null cell line (Harvey and
Levine, 1991). p53−/−, p53 null, PyF, and the PyF parental F111 cells
were infected with MVMp, stained with DAPI, and probed with either
an anti-NS1 or an anti-MVM antibody. Induction of an apoptotic cell
morphology that correlated with NS1 or VP expression was observed
in all cell types after infection (Fig. 7A). The percentage of apoptotic
cells in NS1-positive population was 22% in PyF cells, 17% in p53−/−
cells, 35% in p53 null, and 2.3% in F111 cells and remained below 3% in
all uninfected cultures (Fig. 7C). Low molecular weight DNA was also
detected in infected cells irrespective of their p53 status (Fig. 7B) with
a time-dependent increase in both viral DNA replication forms and
cellular DNA ladders typical of apoptosis which was identiﬁed also by
Southern blot analysis and 32p MVMp labeled DNA (Franek et al.,
1992). These results showed that MVMp infection induces apoptosis
independent of p53 activity.
MVMp NS1-induced G1 arrest is independent of p53 activity
p53 is involved in the control of the G1/S checkpoint, blocking
cell cycle progression, and/or triggering apoptosis in dividing cells
following cell stress and DNA damage (Canman et al., 1994;
Vogelstein et al., 2000). Morita et al. (2003) have reported that
infection with parvovirus B19 or transfection with a B19–NS1 ex-
pression vector induces G1 arrest. We therefore determined whether
MVMp infection blocked cells in G1 despite the p53 down regulation
(see above). To this end, N314 cells, which carry a temperature-
dependent p53 allele, were infected with MVMp (5 pfu/cell). Infected
and mock-treated cells were incubated at 32 or 37 °C for 24 h and
stained with propidium iodide and their respective DNA contents
measured by FACS (Fig. 8). The results showed an accumulation of
infected cells in G1, both in the presence and absence of functional
p53. A pre-G1 peak of apoptotic cells was also observed at both
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Fig. 3. Caspase 9 and caspase 3 activity in MVMp-infected PyF cells. A. PyF cells were infected with MVMp (5 pfu/cell) or transfected with 7.5 μg HAtBId plasmid as a positive control.
Protein lysates were prepared at 12 and 20 h after infection or 24 and 40 h after transfection. Caspase 9 activity was measured using the speciﬁc ﬂuorogenic peptide substrate LEHD-
AMC. For each lysate, accumulation of the ﬂuorescent AMC reaction product (O.D) was measured at the time intervals following the addition of the substrate. B. PyF cells were
infected with MVMp (5 pfu/cell) or transfected with 7.5 μg pHAtBID plasmid as a positive control. Thirty hours after infection or forty hours after transfection, cell extracts were
prepared. Caspase 3 activity was measured using the caspase substrate (Ac-DEVD-pNA) in the presence or absence of the caspase 3 inhibitor (Ac-DEVD-CHO). The accumulation of
reaction products was measured by spectrophotometry at the indicated times following substrate addition.
236 M. Mincberg et al. / Virology 412 (2011) 233–243temperatures, conﬁrming that apoptosis can be induced by the virus
independently of p53.
Discussion
The data presented here indicate that MVMp infection or transient
NS1 expression in permissive PyF-transformed rat ﬁbroblasts triggers
host–cell apoptosis. Analysis of apoptotic pathway elements showed
that the initiator caspase, caspase 8, was not activated, whereas both
caspase 9 and caspase 3 were. We observed cytosolic release of cy-
tochrome c and Apaf1 and a reduction in the mitochondrial membrane
potential, pointing to inductionof themitochondrial apoptosis pathway.
Induction of this pathway did not stimulate p53 accumulation and
apoptosiswas achieved similarly in infected p53 null and p53+/+ cells.
At least in these hosts, MVM-mediated apoptosis is not modulated by
p53.
The resultsmaybecompared todata fromotherparvoviruses related
to MVMp. The Adeno-associated virus type 2 Rep78 gene expressionwas shown to induce apoptosis in human cells independently of p53 via
caspase 6 (Garner et al., 2007; Raj et al., 2001; Schmidt et al., 2000). H-1
virus infection of hepatoma cells induced a more efﬁcient apoptosis in
cells lacking p53 than wild type p53 positive cells (Sieben et al., 2008).
Erythrovirus B19 infection induced apoptosis through caspase 3 and
caspase 9 activation but not caspase 8 in primary hepatocytes and a
hepatocellular carcinoma cell line (Poole et al., 2004). Caspase 3
activation was detected in cells infected by AAV (Schmidt et al., 2000).
The data show that MVMp, like other parvoviruses, induces cell death
through an apoptosis pathway that is independent of p53 or evenmore
pronounced in p53 null cells and involves caspases 3 activation. Since
MVMp infection and NS1 expression trigger the same apoptotic
pathway, we propose that this intracellular pathway is dependent on
NS1 interactions with the host intracellular regulatory proteins.
p53 may directly induce apoptosis through several pathways,
which may be transcriptionally dependent or independent. The
outcome is G1 arrest or apoptosis, depending on a complex network
of regulatory signals (Yonish-Rouach, 1996).
Fig. 4.Mitochondrial membrane potential following MVMp infection. Constant numbers of PyF cells were infected with MVMp 5 pfu/cell. At deﬁned times after infection, the cells
were collected and prepared for ﬂow cytometric analysis using DiOC6 to measure the mitochondrial membrane potential (Δψm). Uninfected cells with intact mitochondria are more
ﬂuorescent than infected cells. The proportion of depolarized, apoptotic cells (less ﬂuorescence) increases with time (% Gated). The window M1 was deﬁned by the ﬂuorescence
signal spread that covered the entire population of completely depolarized cells (CICCP treated). The results are summarized in the adjacent table.
237M. Mincberg et al. / Virology 412 (2011) 233–243Following our observation that MVMp-induced apoptosis is p53
independent, we analyzed the effect of MVMp infection on cell cycle
progression in conditional p53 null cells. We found that infected cells
showed G1 arrest and a pre-G1 peak of apoptotic cells regardless of
p53 activity. Schmidt et al. (2000) similarly showed that AAV-Rep78
protein expression induced apoptosis independently of p53 with
concomitant accumulation of cells in G1. Morita et al. (2003) reported
that infection of erythroid precursor cells with B19 induced apoptosis
and G1 and G2 cell cycle arrest. Interestingly, they also reported thatB19-NS1 expression in the same cells induced G1 but not G2 arrest
suggesting that other factors but not NS1, induce G2 arrest (Morita
et al., 2003, 2001); Hristov et al. (2010) reported that both H-1 NS1
expression and H-1 infection are sufﬁcient to induce G2 arrest in
human cells and undergo apoptosis which does not correlate with
change in p53 level.
Previous studies with MVMp have shown that NS1 expression
induces a multistep cell cycle arrest in G1, S, and G2 (Op De Beeck et al.,
1995; Op De Beeck and Caillet-Fauquet, 1997). By comparison, upon
Fig. 5. Levels of proapoptotic proteins following MVMp infection of PyF cells. A. Lysates
of PyF cells either infected with MVMp (5 pfu/cell) or uninfected were prepared 24 h
post infection. Equal volume of the lysates were incubated with the Apoptosis Antibody
Array membrane and detected by chemiluminescence and X-ray ﬁlm according to the
manufacturer. Numbers of spots are as in panel B. B. Relative proapoptotic protein
levels in infected vs. uninfected cells. The exposed Apoptosis Antibody Array from panel
A was quantitated using Quantity One software to integrate signal over the spot area of
each proapoptotic protein. The results are expressed as the ratio of infected/uninfected
values in arbitrary units.
238 M. Mincberg et al. / Virology 412 (2011) 233–243MVMp infection of normal mouse embryonic ﬁbroblasts, an arrest was
observed in S and G2 only (Op De Beeck et al., 2001). The authors
suggest that MVMp-induced cell cycle arrest in S is p53 dependent but
p21cip1 independent,whereas thearrest inG2dependsonbothp53and
its downstream effector p21WAF1/CIP1. The disparity of the cell cycleFig. 6. p53 and NS1 protein accumulation in MVMp-infected PyF cells. PyF cells were infec
extracts were subjected to 10% PAGE and analyzed byWestern blot analysis using (A) anti-p5
controls (C) are a positive p53 cell lysate from a human melanoma cell line and a maltose-results between laboratories may be due to different viruses and
different levels of NS1 expression that correlated with virus–host cell
factors interactions because of the different cell types used or, less likely,
by small variations in the virus stocks.
A still open and important question is howMVMp arrests cells in G1
without p53 activation. One possibility is the interaction of the CREB
binding protein (CBP) with NS1. CBP functions as a coactivator of NS1,
mediating viral and cellular gene expression, including coactivation of
the MVMp-p38 promoter (Ohshima et al., 2001). In addition, CBP
mediates transcriptional activation of p53. The CHI and CH3 domains of
CBP are also targeted by several otherDNAviral proteins such asEBV-Zta
and HPV (Hwang et al., 2001). NS1 binding to CBP have been shown to
interfere with p53 transactivation (Ohshima et al., 2001). Sequestration
of CBP and inactivation of p53has been also proposed for the adenovirus
E1A and HTLV-1 Tax proteins (Harrod et al., 2000; Nicot et al., 2001;
Scoggin et al., 2001; Zhang et al., 2001). It is possible to induce G1 arrest
in the absence of p53 (Aguero et al., 2005), who reported that
Phenoxodiol, a novel isoﬂavone, induces G1 arrest by speciﬁc loss in
cyclin-dependent kinase 2 activity by p53 independent induction of
p21WAF1/CIP1. Thus, onemight speculate that, in MVMp-infected cells,
NS1 could inactivate p53, interrupting p53 dependent apoptosis and
enabling G1 accumulation as mediated by other regulatory proteins,
such as p21WAF1/CIP1. In transformed Pyf cells, inactivation of p53
occurs by the T large antigen of polyomavirus (Caracciolo et al., 2006),
further supporting the idea thatNS1andMVMp inducep53 independent
apoptosis. Further characterization of the interaction between NS1 and
the cellular proteins leading to apoptosis will be pursued.
Understanding this pathway better is of practical signiﬁcance.
MVMp is exquisitely selective against transformed cells, even in the
absence of p53. Since many tumors are p53 negative, thus often
resistant to chemotherapy and radiation (Campling and El-Deiry,
2003; Lowe et al., 1994; Morgan et al., 2000; Perego et al., 1996),
further researchmay assist in the development of approaches towards
eradicating treatment-resistant tumors lacking p53.
Materials and methods
Cells
PyF are polyomavirus transformed of F111 Fisher rat ﬁbroblasts
cells (Guetta et al., 1990); F111 are Fisher rat ﬁbroblasts. N314 areted with MVMp (5 pfu/cell). At the indicated times following infection, 40 μg protein
3 and anti β-actin as an internal control and (B) anti NS1 polyclonal antibodies. Positive
binding NSI fusion protein (MBP-NS1) as a size marker in panels A and B, respectively.
Fig. 7. Apoptosis in MVMp-infected p53+/+ and p53 null ﬁbroblasts. Equal numbers of cells from three transformed ﬁbroblast cell lines: PyF (p53+/+), p53 knockout (p53−/−),
and p53 null were infected with MVMp (5 pfu/cell). A. Thirty hours following infection, cells were co-stained with DAPI and anti NS1 polyclonal antibodies. B. At 0, 24, 48, and 72 h
post infection, low molecular weight DNA was extracted and resolved by 1% agarose gel electrophoresis. mRF-monomer and dRF replicative form, indicating viral DNA replication,
were identiﬁed by Southern blot analysis and hybridization with 32p MVMp labeled DNA. Arrows indicate nucleosome ladder-sized DNA bands. C. The percentage of apoptotic cells
was calculated as a fraction of cells with nuclear morphological changes.
239M. Mincberg et al. / Virology 412 (2011) 233–243embryonic ﬁbroblasts derived from a p53 null mouse, which were
stably transfected with a temperature sensitive, p53val135 gene. At
32 °C, p53 is active whereas at 37 °C, it is inactive (Michalovitz et al.,
1990). The cells were obtained from Prof. Moshe Oren, The Weizman
Institute, Rehovot, Israel. p53(−/−) are mouse embryonic ﬁbroblasts
from p53 knockout mice (Jacks et al., 1994). p53 null is an established
cell line of Balb/c 3T3 origin that lost both p53 alleles during
immortalization (Harvey and Levine, 1991). All cell lines were
cultured as monolayers in Dulbecco's modiﬁed essential medium
supplemented with 5% or 10% inactivated fetal calf serum at 37 °C, 5%
CO2.
Virus
Minute virus of mice ﬁbrotropic strain, MVMp, was grown in
Ehrlich ascites (EA) cells in suspension, and virus infectivity was
determined by plaque assay on monolayers of A9 cells (Tattersall,
1972). MVMp infection was carried out as follows. The cells were
incubated for 1 h at 37 °C in 1 ml of DMEMwithout supplements with
or without the virus (multiplicity of infection was 5 pfu/cell).Plasmids
HAtBID contains a truncated, activated-Bid (t-Bid), which triggers
cytochrome c release (a gift from Dr. Atan Gross, Weizmann Institute,
Rehovot, Israel). pCDNA-NS1 plasmid bears both the NS1 and NS2
sequences under the highly-active constitutive early CMVpromoter. It
was prepared by excising the full NS1 and NS2 sequence from
pMM984 plasmid using BamHI and HindIII restriction enzymes and
inserting into the fragmented pCDNA3.1 vector using EcoRV and
BamHI. NS1 expression by pCDNA-NS1 was conﬁrmed by transient
transfection.
Lipofection–DOTAP transfection assay
At 16 h pre-transfection, 7×105 cells/60 mm plate were seeded.
Lipofection-based transfection was performed according to the
manufacturer's instructions (DOTAP reagent, Roche). Brieﬂy, DNA
and DOTAPwere diluted in 20 mMHEPES buffer (pH 7.4) according to
the manufacturer's protocol. The culture medium was replaced with
freshmedium and the transfectionmixture was dispersed evenly over
Fig. 8. DNA content in p53-active vs. p53-inactive cells following MVMp infection. Equal numbers of N314 cells were infected with 5 pfu/cell of MVMp or left uninfected (control).
The cells were then cultured for 24 h at the p53-permissive temperature, 32 °C, or at the p53-restrictive temperature, 37 °C. The cells were then collected and stained with PI and
effects of MVMp infection on the cell cycle distribution proﬁle were compared and analyzed by ﬂow cytometry. The relative ﬂuorescence intensity of the cell population was
analyzed by the cell cycle software FlowJo (Tree Star, Ashland, USA). The raw results, reﬂecting the cell DNA content (open line), were modeled by the software into populations in
G0/G1, G2/M or sub-diploid, reﬂecting apoptotic cells (ﬁlled curves) and populations in S (hatched curve). Infection of both cell lines by the virus induced the appearance of a pre-G0/
G1 peak, representing cells undergoing apoptosis.
240 M. Mincberg et al. / Virology 412 (2011) 233–243the cells. At the chosen time points, cells were harvested. Transfection
efﬁciency was determined by co-transfection of a β-galactosidase
reporter gene followed by staining assay or immunoﬂuoresence
(Mockli and Auerbach, 2004).
Imunoﬂuoresence assay
About 2×104 PyF cells were grown on cover slips in 24 well plates
and treated by transfection or infection. At designated time points,cells were ﬁxed with 4% paraformaldehyde in phosphate buffered
saline for 10 min and permeabilized with 1% Triton X-100 in
phosphate buffered saline for 10 min and 1% NP-40/PBS for 10 min.
The cells were blocked by incubation in phosphate buffered saline
containing 0.1% Triton and 3% bovine serum albumin for 1 h. The cells
were further washed 2× with 0.2% Tween-20/PBS. For immuno-
ﬂuoresence analysis, the cells were incubated with anti-NS1 poly-
clonal antibody, (Dr. Jean Rommelaere, German Cancer Research
Center, Heidelberg) at room temperature for 30 min, washed and
241M. Mincberg et al. / Virology 412 (2011) 233–243incubated with anti-rabbit-Ig–FITC for 30 min. All reactions were at
room temperature. To highlight the nucleus, the cells were also
stained with 10 μg/ml DAPI/Antifade solution (Millipore). Apoptotic
morphology and NS1 protein expression were identiﬁed by ﬂuores-
cence microscopy.
Western blot analysis
Viral NS1 and endogenous cell cycle proteins were identiﬁed by
immunoblotting. Uninfected and MVMp-infected cells were rinsed
and scraped in cold PBS. Protein extracts were prepared with RIPA
buffer (150 mM NaCl, 0.1 % SDS, 50 mM Tris–HCl (pH 8), 1% NP-40,
0.25% Sodium Deoxycholate, 0.1% bromophenol blue and 2% β-
mercaptoethanol). Equal amounts of proteins from different samples
were fractionated by 10% SDS–polyacrylamide gel electrophoresis and
electrophoretically transferred to a nitrocellulose membrane (Amer-
sham). The following primary antibodies were used: rabbit-anti NS1,
monoclonal anti-p53 (Santa Cruz), caspase 8 (Hypromatrix, Inc), and
peroxidase-labeled anti-rabbit or mouse Ig served as secondary
antibodies (Amersham Biotech). Bands were revealed by chemilumi-
nescence usingWestern Blotting Luminal Reagent (Santa Cruz) and X-
ray ﬁlm detection.
Caspase 9 activity assay
About 2×106 PyF cells were either infected with MVMp (5 pfu/
cell) or transfected with 5 μg of HAtBID plasmid DNA by DOTAP
lipofectin (Boehringer Mannheim). Twelve and twenty hours after
infection or twenty-four and forty hours after transfection, the cells
were harvested and washed once with PBS. Cell pellets were stored at
−70 °C until used. Cells were lysed in 100 μl of CLB1 (20 mM HEPES
pH 7.4, 5 mM EGTA, 5 mM EDTA, 10 μM Digitonin, 2 mM DTT) and
incubated for 30 min at 4 °C. Lysates were then centrifuged for 7 min
at 10,000g and 4 °C. Protein concentration was determined by
Bradford reagent (Bio-Rad). A 50 μl of reaction mixture containing
40 μg protein, 50 μM acetyl-Leu-Glu-His-Asp-aminomethylcoumarin
(LEHD-AMC) substrate (BioVision) and 1× buffer (50 mM HEPES pH
7.4, 1 mM DTT, 0.1% CHAPS) were incubated at 37 °C for 3 h, and
ﬂuorescent AMC formation was measured at 360 nm excitation and
465 nm emission using a microplate spectroﬂuorometer (xFluor4,
TECAN).
Caspase–3 activity assay
About 2×106 PyF cells were either infected with MVMp (5 pfu/
cell) or transfectedwith 5 μg HAtBID plasmid DNA as described above.
To measure caspase 3 activity, cells were lysed in CLB2 buffer (50 mM
HEPES pH 7.4, 1 mM DTT, 0.1% CHAPS) 30 or 40 h respectively after
treatment. The lysates were clariﬁed by centrifugation and the
supernatants were used for the assay. Enzymatic activity reactions
were carried out using the caspase-3 Cellular Activity Assay Kit
(CALBIOCHEM) in a total volume of 100 μl, which included: 20 μg
lysate protein, 20 μl assay buffer (100 mMNaCl, 50 mMHEPES pH 7.4,
10 mM DTT, 1 mM EDTA, 10% Glycerol, 0.1% CHAPS), 200 μM caspase
3 colorimetric substrate (Ac-DEVD-pNA) with or without 0.1 μM of
the speciﬁc inhibitor Ac-DEVD-CHO. Reaction mixtures were incu-
bated at 37 °C in a microplate and caspase 3 activity wasmonitored by
absorbance at 405 nm in an ELISA reader.
Cytosolic proteins extraction
The procedure was done on ice with cold buffers including 1 mM
PMSF–protease inhibitor. The mediumwas removed and the cells were
washed 2× with PBS and then were scraped in 1 ml PBS. The
supernatant was centrifuged for 10 min at 1200 rpm at 4 °C, resus-
pended in 0.5 mlbuffer A (10 mMHEPES, pH 7.9, 1.5 mMMgCl2, 10 mMKCl, 0.5 mM DTT) and incubated for 20 min on ice. The cells, 2×106,
were lysed by 20 passes through a 21G needle. Cell lysis was quantiﬁed
by trypan blue staining followed by microscopy. To separate the
cytosolic fraction, the lysate was centrifuged for 15 min at 4 °C at
12,000 rpm, and the cytosolic supernatant collected.
Apoptosis antibody array assay
About 50 μg of cytosolic proteinswere prepared frommock-treated
or MVMp-infected (24 h.p.i) PyF cells. The proteins were loaded on
PVDF membrane and tested on a selective mitochondrial apoptosis
antibody array™ membrane (Hypometrix) as recommended by the
manufacturer. Speciﬁcally bound proteins were detected by chemilu-
minescence on X-ray ﬁlm. Spots densitometry was done using the
Quantity One program (Bio-Rad) and expressed as a ratio of infected/
uninfected signal in arbitrary units.
Determination of mitochondrial transmembrane potential
An electrical potential-sensitive probe 3,30-dihexyloxacarbocyanine
iodide (DiOC6) was used to measure Δψm as described previously
(Ahmad et al., 2004). Brieﬂy, 2×106 PyF cells were washed once with
PBS, then incubated with DiOC6 (40 nM) for 15 min at 37 °C and
immediately analyzed by ﬂow cytometry with excitation at 488 nm.
Treatment with 50 μM carbonyl cyanide m-chlorophenylhydrazone
(CICCP) was used as a positive control.
Low molecular weight viral DNA extraction from cells
Thirty hours post infection cells (2×106/100 mm dish) were
washed with PBS and viral lowmolecular weight DNAwas isolated by
the Hirt procedure (Hirt, 1967).
Southern blot and hybridization analysis
Lowmolecular weight DNAswere resolved by electrophoresis on a
1% agarose gel. After the DNA was separated, the DNA was
denaturized (0.5 M NaOH, 1.5 M NaCl) and neutralized (0.5 M Tris
pH 7.5, 1.5 M NaCl). The DNA was transferred to nylon membrane by
capillary transfer in 10× SSC. Viral DNA was identiﬁed by hybridiza-
tion with 32p MVMp labeled-DNA in hybridization solution (6× SSPE,
5× Denhardt's solution, 0.5% SDS, 5 mM EDTA, 100 μg/ml Salmon
sperm DNA) for overnight at 65 °C. Blots were washed with three
washing solutions: A. 5× SSC, 0.5% SDS; B. 1× SSC, 0.5% SDS; C. 0.1 SSC,
1% SDS.
FACS analysis
About 2×106 cells were infected with MVMp (5 pfu/cell) for 24 h.
The cells were collected by centrifugation, and the pellet was
resuspended in 0.5 ml PBS. Eighty percent ethanol was added drop
by drop to a ﬁnal concentration of 70% at 4 °C. The cells were then
washed 3× with PBS. The pellet was resuspended in 0.5 ml buffer
(PBS, 0.1% Triton X-100) and treated with 30 μg/ml RNase for 1 h at
37 °C. Ten micrograms per milliliter of propidium iodide (PI) was
added before FACS analysis (FACS-Star. Becton Dickinson, using the
cell cycle analysis program, FlowJo, Tree Star, Inc. Ashland, OR USA).
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